Epilepsy in Sub-Saharan Africa (SSA)

This initiative aims at connecting people, ideas, proposals and suggestions for a brighter future for patients in Sub-Saharan Africa suffering from #epilepsy.

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

NeuroSolve project aims to improve health outcomes for patients with neurocysticercosis (NCC) in sub-Saharan Africa. NCC, a Neglected Tropical Disease caused by Taenia solium, is a major cause of acquired epilepsy in middle-and-low-income countries.

[NeuroSolve @Neuro_Solve]

The #NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka, hosted by the University of Zambia #UNZA. This research aims to implement a superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa.

[NeuroSolve @Neuro_Solve]

A NeuroSolve poster was presented at the European Congress on Tropical Medicine and International Health 2023. NeuroSolve is research aiming to implement a superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa.

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Neurocysticercosis (NCC) is a leading cause of epilepsy in several LMCIs. The endemicity of NCC and the gap of epilepsy care in sub-Saharan African countries suggest exploring synergies/integrations between the respective interventions https://t.co/bfZSjqSS9K

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

World Health Organization Unanimously Approves Plan to Improve Epilepsy Care, Reduce Stigma https://t.co/6AtHMJoyqa
#epilepsy #subsaharanafrica #clinicalresearch

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

This year's International #epilepsyday falls on #valentinesday !.
Epilepsy is treatable and in Sub-Saharan Africa it is estimated that millions people have #epilepsy . Epilepsy is not uncommon. Epilepsy is hidden.

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

#AfricaDay #SustainableDevelopment #epilepsyinsubsaharanafrica

[R-Evolution Worldwide Community Interest Company @R_EvolutionWW]

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.
May 7, 2021 https://t.co/rWB2y26bxU.
The symposium will be live streamed here (no registration required): https://t.co/jUnvthJh3h
Passcode: sN6yzc

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Treatment gap refers to the percentage of people who have #epilepsy but do not receive any treatment for their #seizures. Treatment gaps are as high as 90-95% in many African countries https://t.co/7wRSzFuDht
#epilepsyisglobal #LMICs #globalhealth #epilepsyinsubsaharanafrica #ncd

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

The International Bureau for #epilepsy - Africa Region just recently concluded training on the Africa Epilepsy Advocacy Toolkit: https://t.co/PYKlLDpEp1
#epilepsyinsubsaharanafrica

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

The vEEG (Electroencephalograph with video recording) has finally arrived in MALAWI, Community of Sant’Egidio in Blantyre. Donated by SIN (Italian Society of Neurology) it will allow diagnosis and the monitoring of epilepsy: https://t.co/87HllYsU09
#epilepsyinSSA #epilepsy #lmics

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Epilepsy can also be caused by river blindness (onchocerciasis), affecting 15.5 million people, mainly in sub-Saharan Africa. Synergies between respective interventions & integrated diseases management to strengthen their effectiveness: https://t.co/ZEsigdckaZ
#epilepsyinSSA

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

https://t.co/30DclFpq16
#epilepsy #epilepsyinSSA #LMICs #SDGs

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

In Sub-Saharan Africa (SSA), neurocysticercosis (NCC) is a cause of epilepsy. Endemicity of NCC and gap of epilepsy care in SSA countries suggest exploring synergies between their respective interventions to increase long term impact and sustainability: https://t.co/ceOYdG4aCa

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

The implementation in Mozambique of the WHO Program for “Reducing the Epilepsy Treatment gap” achieved significant results by integrating the care and treatment for people with #epilepsy at primary health care level: https://t.co/SgbBrzdDFT
#epilepsyinSSA #subsaharanafrica

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Aimed at making epilepsy an health priority in #Africa, the #UTETEZI project reached phase 2 in some Sub-Saharan African countries, including #eSwatini (formerly Swaziland), Zimbabwe, Zambia, South Africa, and Kenya https://t.co/TyJJoLlXFV
#epilepsyinsubsaharanafrica #epilepsy

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Ranked 6th by Newsweek among "The best specialized hospitals in the world 2021", the BESTA Neurologic Institute (Milan, ITALY) is also at the forefront of the #epilepsy care in Sub-Saharan African countries: https://t.co/3aPYmcVzA5
#epilepsyinSSA #subsaharanafrica

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Effective inter- and trans-disciplinary approaches to reduce #epilepsy correlated with tropical neglected & other infectious diseases endemic in Sub-Saharan African countries (e.g. neurocysticercosis, onchocerciasis, malaria, HIV): https://t.co/zs75sV94m3
#epilepsyinSSA #LMICs

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

The International Bureau for Epilepsy (IBE) Africa represents more than 20 associations in 22 countries doing epilepsy awareness, advocacy, economic empowerment & treatment in Africa, where majority of people can't get treatments: https://t.co/Jho5gizanx
#epilepsy #epilepsyinSSA

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

About 26 million people live in sub-Saharan African (SSA) nations where there are no neurologists, and 270 million live in nations where there are fewer than 5 neurologists per country: https://t.co/DMQfWVG9AA
#epilepsyinSSA #epilepsy

[Epilepsy in Sub-Saharan Africa (SSA) @InAfrica]

Epilepsy is the most common neurological condition encountered by specialists in the #WHO African region which is comprised of 47 countries representing Sub-Saharan Africa (SSA): https://t.co/NOjdsB9aNu.
#epilepsy #epilepsyinSSA #lmics #sdgs2030